There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), Crispr Therapeutics AG (CRSP – Research Report) and G1 Therapeutics (GTHX – Research Report) with bullish sentiments.
Sarepta Therapeutics (SRPT)
In a report issued on October 11, Brian Skorney from Robert W. Baird maintained a Buy rating on Sarepta Therapeutics, with a price target of $110.00. The company’s shares closed last Wednesday at $83.22, close to its 52-week low of $65.30.
According to TipRanks.com, Skorney is a 3-star analyst with an average return of
Sarepta Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $119.30, representing a 34.2% upside. In a report issued on September 27, Leerink Partners also initiated coverage with a Buy rating on the stock.
See Insiders’ Hot Stocks on TipRanks >>
Crispr Therapeutics AG (CRSP)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Crispr Therapeutics AG yesterday and set a price target of $125.00. The company’s shares closed last Wednesday at $96.77, close to its 52-week low of $84.38.
According to TipRanks.com, Bayko is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Crispr Therapeutics AG with a $158.90 average price target, implying a 71.2% upside from current levels. In a report issued on October 12, Piper Sandler also maintained a Buy rating on the stock with a $180.00 price target.
G1 Therapeutics (GTHX)
BTIG analyst Thomas Shrader maintained a Buy rating on G1 Therapeutics yesterday and set a price target of $51.00. The company’s shares closed last Wednesday at $12.61, close to its 52-week low of $10.81.
According to TipRanks.com, Shrader is a 4-star analyst with an average return of
G1 Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $51.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SRPT:
- Analysts Offer Insights on Consumer Goods Companies: Ebay (EBAY), The Estée Lauder Companies (EL) and Albertsons Companies (ACI)
- Analysts Offer Insights on Conglomerates Companies: Aptiv (APTV) and Emerson Electric Company (EMR)
- Analysts Offer Insights on Services Companies: Charles River Labs (CRL), Domino’s Pizza (DPZ) and Expedia (EXPE)
- Analysts’ Opinions Are Mixed on These Financial Stocks: Blackrock (BLK) and VEREIT (VER)
- Analysts Are Bullish on Top Technology Stocks: Aspen Technology (AZPN), Autodesk (ADSK)
